Comment on "Toxic epidermal necrolysis (TEN) after first dose of Pfizer (BNT162b2) vaccination and pharmacogenomic-based-point-care support: First case report in pediatric and review of literature"
Pediatr Dermatol
.
2022 Jul;39(4):671-672.
doi: 10.1111/pde.14987.
Authors
Sylvia Aide Martinez-Cabriales
1
2
3
,
Neil H Shear
1
2
Affiliations
1
Department of Medicine, Dermatology Division, University of Toronto, Toronto, Ontario, Canada.
2
Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
3
School of Medicine Autonomous, University of Nuevo Leon, Monterrey, Mexico.
PMID:
36000935
PMCID:
PMC9538367
DOI:
10.1111/pde.14987
No abstract available
Publication types
Case Reports
Review
Comment
MeSH terms
BNT162 Vaccine* / adverse effects
Child
Humans
Pharmacogenetics
Stevens-Johnson Syndrome* / genetics
Vaccination / adverse effects
Substances
BNT162 Vaccine